Travere Therapeutics (TVTX) Net Cash Flow Growth (5y) (2018 - 2026)
Travere Therapeutics (TVTX) Net Cash Flow Growth (5y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Travere Therapeutics |
5.07 Bn |
4.99 Bn |
102.38 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-17.40% |
| Dec 31, 2025 |
31.31% |
| Sep 30, 2025 |
24.30% |
| Jun 30, 2025 |
-41.85% |
| Mar 31, 2025 |
-9.45% |
| Dec 31, 2024 |
66.62% |
| Sep 30, 2024 |
18.66% |
| Jun 30, 2024 |
-31.21% |
| Mar 31, 2024 |
15.14% |
| Dec 31, 2023 |
-40.97% |
| Sep 30, 2023 |
-20.16% |
| Jun 30, 2023 |
-35.44% |
| Mar 31, 2023 |
32.76% |
| Dec 31, 2022 |
-208.59% |
| Sep 30, 2022 |
-58.17% |
| Jun 30, 2022 |
-29.10% |
| Mar 31, 2022 |
154.23% |
| Dec 31, 2021 |
-34.85% |
| Sep 30, 2021 |
91.30% |
| Jun 30, 2021 |
-96.50% |
